Diseases of Pulmonary Vasculature

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

By

Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

By

Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

By

Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.

Pulmonary Compliance Predictive of Mortality in PAH Associated With Adult CHD

Pulmonary Compliance Predictive of Mortality in PAH Associated With Adult CHD

By

Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

By

Nebulized glycopyrrolate improves lung function and patient-reported outcomes in patients with moderate to very severe COPD.

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

By

Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

By

Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

By

Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.

Prognostic Vaue of CT Signs of Pulmonary Veno-occlusive Disease for Survival

Prognostic Vaue of CT Signs of Pulmonary Veno-occlusive Disease for Survival

By

Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline pulmonary hypertension is associated with increased risk of mortality in patients undergoing right heart catheterization.

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

By

Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

By

Future clinical trials on pulmonary arterial hypertension should include patients from diverse racial and ethnic backgrounds.

Use of 6-Minute Walk Test in Idiopathic Pulmonary Fibrosis

Use of 6-Minute Walk Test in Idiopathic Pulmonary Fibrosis

Guidelines are needed for use of the six-minute walk test in patients with idiopathic pulmonary fibrosis.

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

By

The most common chronic respiratory morbidity affecting preterm neonates is bronchopulmonary dysplasia.

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

By

Right ventricular base/apex ratio during systole can discriminate between types of pulmonary hypertension.

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Quality of life in patients with idiopathic pulmonary fibrosis can be significantly affected by depression and anxiety.

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

By

Patients with saddle and nonsaddle pulmonary embolism have similar short-term outcomes, despite more serious symptoms being present in saddle pulmonary embolism.

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

By

The European Society of Cardiology and the European Society for Vascular Surgery have developed new guidelines on the diagnosis and treatment of peripheral arterial disease.

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

By

Patients with high-risk obstructive sleep apnea are almost 4 times more likely to have postoperative complications vs patients with low-risk obstructive sleep apnea.

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

By

Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

By

People with obstructive sleep apnea could have a higher risk for hypercoagulability.

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

By

Bosentan has been approved for use in pediatric pulmonary arterial hypertension in children aged 3 years or older.

Selexipag Associated With Reduced Morbidity, Mortality Risk in Connective Tissue Disease-Associated PAH

Selexipag Associated With Reduced Morbidity, Mortality Risk in Connective Tissue Disease-Associated PAH

By

In patients with connective tissue disease-associated pulmonary arterial hypertension, selexipag may reduce risk for morbidity and mortality.

Survival in SLE-Related Pulmonary Arterial Hypertension Linked to Autoimmune Antibodies

Survival in SLE-Related Pulmonary Arterial Hypertension Linked to Autoimmune Antibodies

By

Anti-U1 ribonucleoprotein antibodies may increase chances of survival in patients with pulmonary arterial hypertension as a complication of systemic lupus erythematosus.

Lower Extremity Edema in a Woman With Heart Failure: A Case Study

Lower Extremity Edema in a Woman With Heart Failure: A Case Study

By

A middle-aged woman recently diagnosed with diastolic left heart failure now has increasing fatigue and worsening lower extremity edema.

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

By

The risk of perioperative complications is increased by many factors in patients undergoing thoracic surgery.

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

By

Opioid use increases cardiac event risk in older adults with chronic obstructive pulmonary disease.

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

By

Pulmonary artery to aorta ratio measurement can effectively predict survival in patients with idiopathic pulmonary fibrosis.

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

By

Multiple factors have influenced a 6-minute reduction in sarcoidosis-associated pulmonary hypertension.

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

By

Mean arterial pressure in patients with peripheral artery disease decreased as a result of antihypertensive medication.

Sign Up for Free e-Newsletters